India glycols Limited has submitted its quarterly compliance certificate to stock exchanges, fulfilling regulatory requirements under SEBI's depositories regulations for the quarter ended 31st March, 2026.

Regulatory Filing Details

The company filed the certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 with both BSE Limited and National Stock Exchange of India Limited on April 3, 2026. The submission was made by Ankur Jain, Head (Legal) & Company Secretary of India Glycols Limited.

Registrar Compliance Certificate

MCS Share Transfer Agent Limited, serving as the registrar and share transfer agent for India Glycols Limited, issued the compliance certificate on April 2, 2026. The certificate confirms adherence to regulatory requirements for the dematerialization process during the quarter.

Regulatory Framework

The filing falls under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which mandates quarterly certification of compliance with dematerialization processes. This regulation ensures proper handling of securities conversion from physical to electronic form and maintenance of accurate records.

Stakeholder Communication

Copies of the certificate were also forwarded to both depositories - National Securities Depository Limited (NSDL) and Central Depository Services (India) Limited (CDSL) - ensuring comprehensive regulatory compliance across all relevant authorities.

The submission demonstrates India Glycols Limited's commitment to maintaining regulatory compliance and transparent communication with market infrastructure institutions and investors.

India Glycols Limited achieved a significant milestone in its corporate restructuring journey with unanimous approval from both equity shareholders and unsecured creditors for the proposed demerger scheme. The company successfully conducted two separate meetings on March 24, 2026, as mandated by the Hon'ble National Company Law Tribunal (NCLT), Allahabad Bench, securing complete stakeholder support for the arrangement.

Equity Shareholders Meeting Results

The equity shareholders meeting, conducted through video conferencing at 11:00 A.M. (IST), witnessed participation from 49 shareholders out of 54,019 total shareholders on record. Shri L.N. Gupta, a retired IAS officer and former NCLT member, served as the tribunal-appointed chairperson for both meetings.

The voting results demonstrated overwhelming support across all categories, with promoter and promoter group shareholders providing 100% approval with 3,99,67,854 votes in favour. Public institutions similarly voted unanimously with 39,81,677 votes, while public non-institutions recorded 99.9997% approval with only one dissenting vote out of 2,99,095 total votes.

Unsecured Creditors Meeting Outcome

The unsecured creditors meeting, held at 02:00 P.M. (IST) on the same day, achieved complete consensus with 100% votes in favour of the demerger scheme. Out of 575 total unsecured creditors on record as of the cut-off date (November 15, 2025), 27 creditors attended the meeting through video conferencing.

Demerger Scheme Structure

The approved scheme of arrangement involves the demerger of India Glycols Limited into two separate entities under Sections 230 to 232 of the Companies Act, 2013. The restructuring will create Ennature Bio Pharma Limited as Resulting Company 1 and IGL Spirits Limited as Resulting Company 2, with India Glycols Limited serving as the demerged company.

Voting Process and Compliance

Both meetings maintained strict compliance with SEBI Listing Regulations, particularly Regulation 30 and Regulation 44(3). Remote e-voting was conducted from March 20, 2026, at 9:00 A.M. to March 23, 2026, at 5:00 P.M. (IST), with additional e-voting facilities available during the meetings and for 15 minutes post-conclusion.

CA Sumit Agrawal, appointed as scrutinizer by the NCLT, confirmed that both voting processes were conducted in a fair and transparent manner. The scrutinizer's reports validated that the resolutions were passed with the requisite majority as per the provisions of Sections 230 to 232 of the Companies Act, 2013.

Regulatory Framework and Next Steps

The unanimous approvals from both stakeholder groups empower the Board of Directors to proceed with implementing the demerger scheme, including making necessary modifications as required by regulatory authorities. The company has fulfilled its disclosure obligations by hosting meeting results and scrutinizer reports on its website at www.indioglycols.com and on NSDL's e-voting platform.

The successful completion of both meetings represents a crucial step in India Glycols Limited's corporate restructuring initiative, with the company now positioned to move forward with the NCLT-sanctioned demerger process.